BlackRock, Inc. Increases Stake in Elanco Animal Health Inc

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership in Elanco Animal Health Inc. As of the effective date of October 17, 2025, BlackRock, Inc. beneficially owns 44,021,766 shares of Elanco's common stock, representing 8.9% of the total outstanding shares. This marks a significant increase from their previous holdings, with a value change of $613,485,611.72 and a shares change of 20,950,295. The filing indicates that BlackRock, Inc. has sole voting power over 42,268,742 shares and sole dispositive power over all 44,021,766 shares. The filing also certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing the control of the issuer.